FindTrial
Sign In

A clinical trial to study the effects of weight loss surgery on obese patients with fatty liver disease.

Non Alcoholic Steatohepatitis Obesity Surgery Trial - NASHOST

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/01/003300
Enrollment
100
Registered
2013-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Morbidly obesity with fatty liver disease

Interventions

Intervention1: Bariatric surgery: Intervention is Bariatric surgery Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

GEM Hospital and research center private limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Morbidly obese patients with fatty liver detected clinically or by radilogical studies willing to participate in the trial after written and informed consent Morbid Obesity being defined as those with BMI >40 or those with BMI >35 with obesity related comorbid illness

Exclusion criteria

Exclusion criteria: Patients having significant alcohol intake , chronic viral infection of liver, metabolic diseases affecting liver or exposure to hepatotoxic drugs and those who are not willing to undergo a repeat liver biopsy

Design outcomes

Primary

MeasureTime frame
Change in liver biopsy scoreTimepoint: 6 months—

Secondary

MeasureTime frame
Metabolic profile BMI Abdominal circumference Body weight HOMA score Medication requirement Body fat percentage Patient satisfactionTimepoint: 1,3 and 6 months—

Countries

India

Contacts

Public ContactDr Praveen Raj

GEM Hospital

praveenraj@me.com9894200200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026